Arcellx, Inc. advances anito-cel CAR-T therapy for relapsed/refractory multiple myeloma. Click for ACLX pivotal trials, FDA ...

Elrexfio is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager that binds to BCMA on multiple ... an immunomodulatory agent, and an anti-CD38 monoclonal antibody. For patients ...

Panelists discuss the growing promise of GPRC5D-targeted therapy in relapsed/refractory multiple myeloma, highlighting MonumenTAL-1 trial data showing encouraging responses in heavily pretreated ...

RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Immunotherapy using CAR T cells is finding ever more applications. In addition to their use in the treatment of blood and ...